Are GLP-1 prescribing standards actually too loose?

What did @jaymiemoran actually say?

The core claim here is that GLP-1 weight loss injections cause serious muscle loss, that most users aren't doing enough to prevent it, and that this will trigger a health crisis, including osteoporosis in people in their 20s and 30s. The creator also stated that "85 to 40% of the weight that you lose is muscle" and that people on these drugs routinely drop to 500 calories a day for months.

To be fair, the creator isn't anti-medication. They're making a specific point about what happens when people take GLP-1 drugs without changing their exercise or protein intake habits. That framing is worth keeping in mind before dissecting the details, because some of it is legitimate and some of it is exaggerated in ways that matter.

Does the science back this up?

Partially, and the caveats are significant. Muscle loss during caloric deficit is real and well-documented, and GLP-1 drugs do create steep caloric deficits. But the specific numbers thrown out here are off, and the osteoporosis prediction is speculation dressed up as inevitability.

A 2023 NEJM trial of tirzepatide (Jastreboff et al., NEJM 2022) showed participants lost roughly 20% of body weight, with lean mass comprising about 25-39% of total weight lost, not 40-85%. That range is consistent with what we see in most diet-induced weight loss studies. The 85% figure the creator mentions has no credible citation behind it and is not supported by current clinical data. Research on semaglutide from the STEP trials (Wilding et al., NEJM 2021) similarly showed fat mass as the dominant component of weight lost. Protein intake and resistance training do meaningfully reduce lean mass loss, as shown by Cava et al. (2017, Nutrients), which the creator correctly identifies.

The 500-calorie-a-day claim is anecdotal. GLP-1 drugs suppress appetite significantly, but there is no clinical evidence that most users sustain 500-calorie intake for months. That is an extreme restriction that most people would not tolerate even with appetite suppression.

What did they get wrong (or right)?

Right: muscle loss during GLP-1-induced weight loss is a real and underappreciated concern. The creator is correct that resistance training, adequate protein, and sleep all help preserve lean mass. That advice is evidence-based. The point about rebound weight gain consisting disproportionately of fat rather than muscle, sometimes called "fat overshoot," has some support in obesity literature (Dulloo et al., 2015, Obesity Reviews).

Wrong: the "85 to 40%" muscle loss statistic is either a misquote, a misremembering, or fabricated. It's also stated backwards, which suggests it wasn't recalled from a specific source. The clinical data puts lean mass loss closer to 25-40% of total weight lost, which is meaningful but not catastrophic, especially with appropriate lifestyle support. The osteoporosis-in-your-20s prediction is alarmist speculation. Bone density loss from weight loss is documented in older populations and bariatric surgery patients, but projecting a generation-wide osteoporosis epidemic from current GLP-1 use is not supported by any published evidence. It's a hypothesis, not a finding.

What should you actually know?

Muscle loss on GLP-1 drugs is a legitimate clinical concern and one that prescribers should be actively discussing with patients. A 2024 paper by Bettinelli et al. (Clinical Nutrition) specifically flagged the need for protein and resistance exercise guidance alongside GLP-1 prescriptions. The creator's practical recommendations, protein, lifting, sleep, are correct and grounded in evidence.

What the creator gets wrong is the catastrophizing. The framing that this "is gonna cause a serious health epidemic" and that we're "sprinting towards" mass osteoporosis in young adults treats a manageable clinical challenge as an unavoidable disaster. That kind of framing discourages people who genuinely benefit from these medications from using them, or creates unnecessary anxiety in people who are using them responsibly.

The honest picture: GLP-1 drugs produce real fat loss with some lean mass loss. That lean mass loss can be substantially reduced with resistance training and protein targets around 1.2-1.6g per kg of body weight, consistent with ISSN guidelines (Stokes et al., 2018, Journal of the International Society of Sports Nutrition). The drugs are not magic pills, and the medical community should do better at giving patients complete guidance. But they are also not a ticking time bomb.